Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and therapy are altering the survival rates for patients with blood cancers. Research studies continue to explore these innovative approaches, offering hope for more successful treatment options.